Physician
Mark and Kambour MD PA
Mark and Kambour MD PA was paid $776K by Medicaid between Jan 2018 and Nov 2024, across 58 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 57% of everything it billed.
33Billing provider infoMARK AND KAMBOUR MD PA
MIAMI LAKES, FL 33014
MIAMI LAKES, FL 33014
33aNPI1760456172assigned 02/14/2006
33bProvider typeCytopathology Physician
28Total paid$776K
24GClaims55,580
24DCodes billed58
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Cytopathology Physician providers in Florida
Rank by total paid#8 of 14
Median peer was paid$776K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GRATTENDICK, MICHAEL controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,944 | $15K | |
| 2019 | 21,050 | $309K | |
| 2020 | 7,583 | $187K | |
| 2021 | 5,889 | $101K | |
| 2022 | 1,932 | $49K | |
| 2023 | 2,038 | $71K | |
| 2024incomplete | 1,144 | $44K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 57% | 14,545 | 11,859 | $439K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 8.9% | 5,071 | 3,104 | $69K |
| 87481 | 7.3% | 3,588 | 700 | $57K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 5.7% | 5,057 | 3,095 | $44K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 4.3% | 2,540 | 2,379 | $34K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.2% | 3,462 | 2,066 | $25K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.0% | 1,147 | 1,094 | $23K |
| 88312 | 2.0% | 781 | 654 | $16K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.0% | 4,475 | 1,020 | $16K |
| 80053 | Comprehensive metabolic panel | 1.6% | 1,075 | 798 | $13K |
| 87653 | 1.4% | 834 | 526 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 966 | 592 | $7K |
46 more codes
| 88141 | <1% | 235 | $4K | |
| 88342 | <1% | 207 | $4K | |
| 88304 | <1% | 150 | $3K | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 195 | $2K |
| 80076 | <1% | 393 | $2K | |
| 87070 | <1% | 335 | $1K | |
| 88142 | <1% | 95 | $1K | |
| 81001 | <1% | 995 | $935.83 | |
| 83735 | <1% | 595 | $898.33 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 176 | $797.13 |
| 87625 | <1% | 32 | $437.94 | |
| 87511 | <1% | 379 | $434.68 | |
| 82374 | <1% | 263 | $294.74 | |
| 81003 | <1% | 381 | $276.78 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 297 | $270.91 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 874 | $193.25 |
| 85027 | <1% | 1,568 | $190.17 | |
| 84703 | <1% | 711 | $136.20 | |
| 87563 | <1% | 34 | $105.27 | |
| 87430 | <1% | 292 | $81.50 | |
| 84295 | <1% | 269 | $71.03 | |
| 85610 | <1% | 337 | $60.51 | |
| 82310 | <1% | 126 | $53.51 | |
| 82947 | <1% | 263 | $46.84 | |
| 88341 | <1% | 14 | $43.36 | |
| 87807 | <1% | 26 | $30.12 | |
| 84484 | <1% | 384 | $25.44 | |
| 82565 | <1% | 232 | $17.05 | |
| 87040 | <1% | 123 | $17.01 | |
| 83690 | <1% | 370 | $16.51 | |
| 84520 | <1% | 230 | $14.40 | |
| 82435 | <1% | 259 | $13.30 | |
| 84132 | <1% | 262 | $11.91 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 188 | $11.84 |
| 87077 | <1% | 41 | $9.70 | |
| 85730 | <1% | 281 | $8.31 | |
| 84100 | <1% | 75 | $8.25 | |
| 83605 | <1% | 73 | $3.40 | |
| 86900 | <1% | 13 | $3.16 | |
| 87088 | <1% | 58 | $2.60 | |
| 86901 | <1% | 13 | $2.16 | |
| 82962 | <1% | 104 | $0.45 | |
| 82150 | 0% | 51 | $0.00 | |
| 83880 | 0% | 14 | $0.00 | |
| 80320 | 0% | 13 | $0.00 | |
| 87081 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRATTENDICK, MICHAEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Laboratory Medicine Consultants LTD | Las Vegas, NV | $9.16M |
| Pathology Solutions LLC | Eatontown, NJ | $5.39M |
| Laboratory of Dermatopathology Adx, LLC | Woodbury, NY | $3.57M |
| Cascade Pathology Services, Corp | Portland, OR | $2.52M |
| Laboratory Medicine Consultants LTD | Las Vegas, NV | $2.33M |
| Consultants in Laboratory Medicine of Greater Toledo | Toledo, OH | $2.28M |
| Greensboro Pathology, LLC | Greensboro, NC | $2.16M |
| Dermpath New England, LLC | Boston, MA | $643K |
| Western Pathology Consultants, LTD | Reno, NV | $554K |
| Seacoast Pathology, INC. | Exeter, NH | $392K |
| Hallmark Pathology, P.C. | Melrose, MA | $118K |
| Richard Bernert, LLC | Scottsdale, AZ | $23K |
| Mid-Atlantic Pathology Services, INC. | Sterling, VA | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.